Tafinlar 75 MG (as dabrafenib mesylate 88.88 MG) Oral Capsule

RxCUI: 1425230
RxNorm name: Tafinlar 75 MG (as dabrafenib mesylate 88.88 MG) Oral Capsule
Display name: Tafinlar 75 MG (as dabrafenib mesylate 88.88 MG) Oral Capsule
Full name: Tafinlar 75 MG (as dabrafenib mesylate 88.88 MG) Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:30

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tafinlar	DABRAFENIB	Novartis Pharmaceuticals Corporation	fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	2026-05-20	Warnings, Adverse reactions	Exact identifier rxcui: 1425230

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea	Tafinlar 75 MG Oral Capsule [PSN] · dabrafenib 75 MG Oral Capsule [Tafinlar] [SBD] · Tafinlar 75 MG (as dabrafenib mesylate 88.88 MG) Oral Capsule [SY] · Tafinlar 75 MG Oral Capsule [SY]	4	37	These highlights do not include all the information needed to use TAFINLAR safely and effectively. See full prescribing information for TAFINLAR. TAFINLAR ® (dabrafenib) capsules, for oral use TAFINLAR ® (dabrafenib) tablets for oral suspension Initial U.S. Approval: 2013	20260520